Christine Allen

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Oxide Nanoparticles

Top Venues

Molecular pharmaceutics

Nature communications

Biomacromolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Pauric Bannigan, Riley J Hickman, Alán Aspuru-Guzik, Christine Allen
The Dawn of a New Pharmaceutical Epoch: Can AI and Robotics Reshape Drug Formulation? Advanced healthcare materials (2024)
Pauric Bannigan, Zeqing Bao, Riley J Hickman, Matteo Aldeghi, Florian Häse, Alán Aspuru-Guzik, Christine Allen
Machine learning models to accelerate the design of polymeric long-acting injectables. Nature communications 14 (1) (2023)
Pauric Bannigan, Zeqing Bao, Riley J Hickman, Matteo Aldeghi, Florian Häse, Alán Aspuru-Guzik, Christine Allen
Machine learning models to accelerate the design of polymeric long-acting injectables. Nature communications 14 (1) (2023)
Pauric Bannigan, Zeqing Bao, Riley J Hickman, Matteo Aldeghi, Florian Häse, Alán Aspuru-Guzik, Christine Allen
Machine learning models to accelerate the design of polymeric long-acting injectables. Nature communications 14 (1) (2023)
Pauric Bannigan, Zeqing Bao, Riley J Hickman, Matteo Aldeghi, Florian Häse, Alán Aspuru-Guzik, Christine Allen
Machine learning models to accelerate the design of polymeric long-acting injectables. Nature communications 14 (1) (2023)
Megan G Roberts, Qing Yu, Rachel Keunen, Jieyi Liu, Edmond Chi Ngae Wong, Chandresh Kumar Rastogi, Raymond M Reilly, Christine Allen, Mitchell A Winnik
Functionalization of Cellulose Nanocrystals with POEGMA Copolymers via Copper-Catalyzed Azide-Alkyne Cycloaddition for Potential Drug-Delivery Applications. Biomacromolecules 21 (6) (2020)
Yen Ting Shen, Lucy Wang, James C Evans, Christine Allen, Micheline Piquette-Miller
Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer. International journal of molecular sciences 20 (10) (2019)
Loujin Houdaihed, James C Evans, Christine Allen
Correction to "Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer". Molecular pharmaceutics 16 (10) (2019)
Frantz Le Devedec, Hilary Boucher, David Dubins, Christine Allen
Factors Controlling Drug Release in Cross-linked Poly(valerolactone) Based Matrices. Molecular pharmaceutics 15 (4) (2018)
Shawn Stapleton, Michael Dunne, Michael Milosevic, Charles W Tran, Matthew J Gold, Ali Vedadi, Trevor D Mckee, Pamela S Ohashi, Christine Allen, David A Jaffray
Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics. ACS nano 12 (8) (2018)
Sina Eetezadi, James C Evans, Yen-Ting Shen, Raquel De Souza, Micheline Piquette-Miller, Christine Allen
Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer. Molecular pharmaceutics 15 (2) (2018)
Yen Ting Shen, James C Evans, Gaetano Zafarana, Christine Allen, Micheline Piquette-Miller
BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines. Molecular pharmaceutics 15 (7) (2018)
Loujin Houdaihed, James C Evans, Christine Allen
Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer. Molecular pharmaceutics 15 (9) (2018)
Loujin Houdaihed, James C Evans, Christine Allen
Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic. Molecular pharmaceutics 14 (8) (2017)